No takes yet. Share an insight, caveat, or question.
Analysis shows structural bias impacting cancer risk outcomes in COVID-19 vaccine cohorts, suggesting the need for rigorous validation.
Roccetti Marco (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: